by Steve Lundeberg, Oregon State University Depiction of mRNA therapy. Credit: OSU College of Pharmacy A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new “universal” means of treating COVID-19. Gaurav Sahay and collaborators at OSU and the Texas Biomedical Research Institute demonstrated in a...
by Kathy Katella, Yale University Paxlovid blister pack, partially opened to reveal one Ritonavir tablet and two Nirmatrelvir tablets. Credit: Kches16414/Wikimedia Commons, CC BY-SA 4.0 Most people with COVID-19 will experience a mild illness, and they’ll be able to take care of themselves at home. But some—especially those with underlying health conditions—could benefit from one of several COVID-19...
Neem tree bark extract may provide a useful starting point for new COVID-19 treatments. Nuk2013/Shutterstock Researchers in Colorado and India are researching the bark of the neem tree as a way to treat COVID-19. They learned that an extract from the tree bark, Azadirachta indica, may have antiviral benefits and help reduce symptoms in people with a...
by The Rosalind Franklin Institute Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH A unique type of tiny antibody produced by llamas could provide a new frontline...
by Quinn Eastman, Emory University Figure 1: Trial profile. SOC=standard of care. *Included in the intent-to-treat population. †Includes all randomized participants who received ≥1 dose of study drug and who did not discontinue the study for the reason of ‘lost to follow-up’ at the first post-baseline visit. ‡159 deaths total reported by day 28. There were...
RICHARD HARRIS March 10, 2021 5:01 AM Melissa Cruz elevated her arm after donating COVID-19 convalescent plasma in April 2020, as phlebotomist Jenee Wilson shut down the collection equipment at Bloodworks Northwest in Seattle.Karen Ducey/Getty Images More than half a million Americans have received an experimental treatment for COVID-19 called convalescent plasma. But a year...
UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE IMAGE: CAMILLO RICORDI, M.D., DIRECTOR OF THE DIABETES RESEARCH INSTITUTE (DRI) AND CELL TRANSPLANT CENTER AT THE UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE CREDIT: UNIVERSITY OF MIAMI HEALTH SYSTEM University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived...
by St. Jude Children’s Research Hospital (L-R) Bhesh Sharma, Ph.D., Thirumala-Devi Kanneganti, Ph.D., Rajendra Karki Ph.D., of the Kanneganti Lab at St. Jude Children’s Research Hospital The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children’s Research Hospital scientists have discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ...
by Cleveland Clinic Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19. As COVID-19 continues to spread throughout the world, particularly with cases rising during what some have termed the “fall...
A team of scientists led by Paul Dent, Ph.D., at Virginia Commonwealth University Massey Cancer Center has discovered that an experimental cancer drug called AR-12 inhibits the SARS-CoV-2 virus, the cause of the COVID-19 pandemic, from infecting cells and replicating. Their findings were published online today in the journal Biochemical Pharmacology, and steps are now being...
